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Abstract
Background: Core body temperature is used to stage and guide the management of hypothermic patients, however
obtaining accurate measurements of core temperature is challenging, especially in the pre-hospital context. The Swiss
staging model for hypothermia uses clinical indicators to stage hypothermia. The proposed temperature range for clinical
stage 1 is <35-32 °C (95-90 °F), for stage 2, <32-28 °C (<90-82 °F) for stage 3, <28-24 °C (<82-75 °F), and for stage 4 below
24 °C (75 °F). However, the evidence relating these temperature ranges to the clinical stages needs to be strengthened.
Methods: Medline was used to retrieve data on as many cases of accidental hypothermia (core body temperature <35 °C
(95 °F)) as possible. Cases of therapeutic or neonatal hypothermia and those with confounders or insufficient data were
excluded. To evaluate the Swiss staging model for hypothermia, we estimated the percentage of those patients who
were correctly classified and compared the theoretical with the observed ranges of temperatures for each clinical stage.
The number of rescue collapses was also recorded.
Results: We analysed 183 cases; the median temperature for the sample was 25.2 °C (IQR 22-28). 95 of the 183 patients
(51.9 %; 95 % CI = 44.7 %-59.2 %) were correctly classified, while the temperature was overestimated in 36 patients
(19.7 %; 95 % CI = 13.9 %-25.4 %). We observed important overlaps among the four stage groups with respect to core
temperature, the lowest observed temperature being 28.1 °C for Stage 1, 22 °C for Stage 2, 19.3 °C for Stage 3,
and 13.7 °C for stage 4.
Conclusion: Predicting core body temperature using clinical indicators is a difficult task. Despite the inherent
limitations of our study, it increases the strength of the evidence linking the clinical hypothermia stage to core
temperature. Decreasing the thresholds of temperatures distinguishing the different stages would allow a reduction in
the number of cases where body temperature is overestimated, avoiding some potentially negative consequences for
the management of hypothermic patients.
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Background
Accidental hypothermia is defined as a trunk or a core
temperature of less than 35 °C (95 °F), in the context of
exposure to cold [1]. Information about core body
temperature is used to make decisions about the manage-
ment and triage to appropriate hospital of hypothermic
patients, including avalanche victims. [1, 2] However reli-
able measurements of core temperature are not always
available, especially in pre-hospital settings [3]. The Swiss
staging model of hypothermia, which is based on observa-
tions of the vital signs at presentation, allows core
temperature to be estimated from clinical indicators only
[1] (Table 1). It is specifically adapted for use in pre-
hospital or austere environments and the hypothermia
guidelines recommend that decisions about management
of a hypothermic victim should be based on clinical Swiss
staging if accurate core body temperature measurement
cannot be obtained [1, 4]. The putative correlation between
clinical stage and core body temperature is, however, prin-
cipally based on cases that have not been published in the
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peer-reviewed literature, and is therefore subject to limita-
tions [5]. Our aim was to evaluate the accuracy and value
of the Swiss clinical staging procedure by comparing mea-
surements of core temperature in published case reports of
accidental hypothermia, with predictions based on post hoc
Swiss staging using data from case reports.
Method
We searched MEDLINE to find as many cases of
hypothermia (core body temperature <35 °C) as pos-
sible. We used the keyword ‘hypothermia’ and limited
our search to case reports, without imposing any con-
straints on language or year of publication (last access:
February 1st 2015). Additional relevant articles were
hand-searched from references in retrieved publications.
We analysed cases in which core temperature was
below 35 °C and for which data on clinical parameters
and vital signs at presentation were available (this
allowed cases to be classified clinically using the Swiss
staging procedure). Cases without sufficient data or with
confounding factors, as described below, were excluded.
We also analysed cases where there were initially no
data on vital signs but the patient had survived after re-
suscitation, and fatal cases for which medico-legal exam-
ination was available and confirmed hypothermia as the
cause of death. To ensure that any impairment in con-
sciousness could be firmly attributed to hypothermia
alone we excluded cases with any mention or suspicion
of one of the following potential confounding factors:
acute alcohol or other intoxication, drug overdose, trau-
matic brain injury and medical conditions that could
lead to hypothermia. Cases of therapeutic and neonatal
hypothermia were also excluded. A blood alcohol con-
centration of up to 150 mg/dl was not grounds for ex-
clusion as this is considered the threshold at which signs
of altered consciousness may occur [6]. Daily medication
use was also tolerated.
The following data were collected: age, sex, vital pa-
rameters, first recorded core body temperature, presence
of shivering, occurrence of cardiac arrhythmia, causes of
accidental hypothermia, rewarming method, hospital
survival and neurological outcome.
Consciousness was evaluated using the Glasgow Coma
Scale (GCS), the Alert-Verbal-Pain-Unresponsive (AVPU)
classification, or any other descriptive clinical information
available. Twelve authors were contacted by e-mail to ob-
tain information that was missing from the published re-
port, with 2 additional items of data collected. In view of
the very low rate of documentation of shivering in the first
cohort of cases collected, we decided to stage hypothermia
clinically solely on the basis of state of consciousness and
vital signs. Stage 1 was defined as a GCS score =15 or ‘A’
from the AVPU classification; Stage 2 as a GCS score > 8
and < 15 or ‘V’ from AVPU; stage 3 as a GCS < 9 or ‘P’ or
‘U’ from AVPU; Stage 4 as the absence of vital signs (re-
spiratory rate of 0, no measurable blood pressure, no palp-
able pulse) and GCS = 3 or ‘U’ from AVPU.
Statistical analysis
The percentage of cases that would have been correctly
classified using the Swiss clinical staging procedure was
obtained as the number of patients for which the ob-
served temperature lay within the theoretical range of
temperature associated to his/her clinical stage. A logis-
tic regression has been carried out to explore whether
sex, age, and the cause of the hypothermia influenced
the percentage of cases correctly classified. In each stage
group, a 95 % prediction interval for the temperature
was obtained by adding to and subtracting two standard
deviations from the average calculated in that group. As
an additional analysis, we performed three receiver oper-
ating characteristic (ROC) analyses to determine optimal
temperature thresholds for discriminating between the
four clinical stage groups. For every possible threshold
temperature t we calculated sensitivity as the proportion
of patients in the higher stage group with a temperature
below t, and specificity as the proportion of patients in
the lower stage group with a temperature equal to or
above t. Each threshold t can thus be defined in terms of
an (x,y) pair (sensitivity, specificity). A ROC curve is a
plot of values of sensitivity against one minus specificity.
The area under that curve (AUC) is a measure of how
well a test variable (in this case temperature) discrimi-
nates between two groups. It also represents the prob-
ability that a randomly chosen patient from the higher
stage group will have a lower temperature than a ran-
domly chosen patient from the lower stage group. The
threshold temperature which best discriminates between
Table 1 Swiss clinical staging of hypothermia
Brown et al., 2012 [1] Durrer et al., 2003 [4] Typical core temperature (°C)
Stage 1 Conscious, shivering Clear consciousness with shivering 35 to 32
Stage 2 Impaired consciousness, not shivering Impaired consciousness without shivering <32 to 28
Stage 3 Unconscious, not shivering, vital signs present Unconsciousness <28 to 24
Stage 4 No vital signs Apparent death <24
There are minor differences between the original system developed Durrer et al. [4], and the most recent versions [1, 5]. Each clinical stage is associated with an
estimate of core body temperature
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two group was taken to be the temperature at which the
sum of sensitivity plus specificity was maximal (which is
related to the Youden index) [7]. 95 % Confidence inter-
vals for these threshold temperatures have been calcu-
lated using the bootstrap method.
Results
We identified 183 cases of hypothermia which were suit-
able for analysis (Fig. 1). Their characteristics are pre-
sented in Table 2. Shivering was present in 8 out of 11
patients for whom the information was available. Only 3
of these patients had temperatures corresponding to
Stage 1 hypothermia, 2 to Stage 2, and 3 to Stage 3. Only
3 out of the 8 patients with shivering had a GCS score
of 15 or ’A’ on the AVPU classification. Among the
causes of hypothermia disposable, we found 77 cases of
water exposition, 8 cases of avalanche accident and 26
cases of environmental exposure (snow or wind expos-
ure, fall in a glacier crevasse, cool chamber trapping).
The classification of patients according to clinical stage
and measured core body temperature is presented in
Table 3. Ninety-five out of the 183 patients (51.9 %,
95 % CI: 44.7 %-59.2 %) had a core body temperature
within the predicted range for their clinical stage, i.e.
were correctly classified on the basis of clinical staging,
while the temperature was overestimated in 36 patients
(19.7 %, 95 % CI: 13.9 %-25.4 %) and underestimated in
52 patients (28.4 %, 95 % CI: 13.9 %-25.4 %). Sex, age,
cause and the site of temperature measurement were
not significantly associated to the accuracy of clinical
staging. The observed mean temperature was 31.3 °C for
patients clinically classified as Stage 1, 28.3 °C for those
classified as Stage 2, 25.6 °C for Stage 3 and 22.7 °C for
Stage 4. We observed important overlaps among the
four stage groups with respect to core temperature, the
lowest observed temperature being 28.1 °C for Stage 1,
22 °C for Stage 2, 19.3 °C for Stage 3, and 13.7 °C for
stage 4. In other words, the observed lowest temperature
in the Stage 1 group corresponded to the lowest theoret-
ical temperature for the Stage 2 group, whereas the ob-
served lowest temperature in the Stage 2 and Stage 3
groups were well below the theoretical temperature for
the Stage 3 group. Results were quite similar when re-
placing these lowest observed temperatures with the
lowest bound of a 95 % prediction interval based on a
normal distribution (see the right column in Table 3).
The results of the ROC analyses are shown in Fig. 2. The
optimal temperature threshold for discriminating between
Fig. 1 Flowchart of study cases
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stages were as follows, Stage 1 and Stage 2: 30 °C (actual
cutoff = 32 °C; 95 % bootstrap CI: 28.1 °C -31.5 °C); Stage 2
and Stage 3: 26.6 °C (actual cutoff = 28 °C; 95 % bootstrap
CI: 25.0 °C-29.0 °C); Stage 3 and Stage 4: 24.1 °C (actual
cutoff = 24 °C; 95 % bootstrap CI 20.6 °C-25.3 °C).
Rescue collapse occurred in 15 patients, of whom all
but 1 were in clinical stage 3 at presentation with either
ventricular fibrillation (n = 10), or asystole (n = 5); the
remaining patient was in clinical stage 2 at presentation
(core temperature of 22 °C) [8]. The highest temperature
recorded in a patient who later suffered rescue collapse
was 27.8 °C [9].
Discussion
Correct classification rate and potential clinical
consequences of misclassification
Using the theoretically derived temperature ranges for
clinical stages would result in about 50 % of patients being
assigned to the wrong temperature range. The potential
consequences of such misclassification are variable; they
depend on the scenario considered [1]. Clinically classify-
ing a patient with a core temperature ≥ 32 °C as stage 2
would, at worst, result in more cautious management and
monitoring of the patient, in view of the risk of harmful
arrhythmias when core temperature drops below 32 °C.
Conversely, clinically classifying a patient who actually
had a core temperature <32 °C as stage 1 would result in
underestimation of the risk of cardiac arrest, with poten-
tially serious consequences. Six of our patients in clinical
stage 1 actually had temperatures below the predicted
range for stage 1; the lowest temperature recorded from a
clinical stage 1 patient was 28.1 °C [10], which is very close
to the 28 °C threshold below which the risk of cardiac
arrest increases substantially. Clinically classifying a pa-
tient with a core temperature ≥28 °C as stage 3 would
result in him or her being transported to a hospital cap-
able of providing extracorporeal re-warming rather than
to the nearest hospital. Clinically classifying a patient with
a core temperature < 28 °C as Stage 2 is probably the most
concerning scenario, as it could result in the patient being
transported to hospital without the extracorporeal re-
warming facilities which are indicated in such cases. This
would have been the case for 10 patients in our study, 1 of
whom suffered cardiac arrest during transportation [8].
Misclassification of patients with a temperature <24 °C as
clinical stage 3 has recently been the subject of investiga-
tion; this form of misclassification may result in underesti-
mation of the risk of cardiac arrest, which is extremely
high for patients with a core temperature <24 °C [5].
Finally, the cases of cardiac arrest in patients with a
temperature ≥24 °C and a favourable outcome are pos-
sibly over-reported (publication bias), which could
lead to an unrepresentative selection of Stage 4
hypothermic patients with higher core temperature
than in reality. Hypothermic patients in cardiac arrest
Table 2 Characteristics of the 183 patients included
Age in years, median (IQR) 40 (17;60)
Sex male, n (%) 111 (61)
Temperature in °C, median (IQR) 25.2 (22;28)
First cardiac rhythm, n (%)
Asystole 36 (31)
Sinus rhythm 35 (29.9)
Ventricular fibrillation 23 (19.7)
Atrial fibrillation 13 (11.1)
Others/unknown 66 (36)
Rewarming method (information available for 166 patients), n (%)
ECMO/CPB 62 (37.4)
Haemodialysis 9 (5.4)
Endovascular 5 (3.0)
Others/external rewarming 90 (54.2)
Outcome (CPC available for 125 patients), n (%)
1 149 (81.4)
2 or 3 10 (5.5)
4 1 (0.5)
5 6 (3.3)
Missing information 17 (9.3)
CPB: cardiopulmonary bypass; CPC [16]: cerebral performance categories
(1 = normal or slightly diminished cerebral function, 2 = moderate cerebral
disability, 3 = severe cerebral disability, 4 = coma or vegetative state, 5 = brain
dead); ECMO: extracorporeal membrane oxygenation; IQR: interquartile range
Table 3 Correspondence between clinical stage and the measured temperature for the 183 cases. The increase in the percentage of
cases classified correctly at higher stages was globally non-significant in a chi-square test (p = 0.48) due to the small number of patients
in the Stage 1 and Stage 2 groups. T° = core body temperature in °C
≥32 T° <35 ≥28 T° <32 ≥24 T <28 T° < 24 overall, N (%) mean T ± SDa 95 % CI for mean 95 % prediction intervalb
Stage 1, n (%) 4 6 0 0 10 (5.5) 31.3 ± 2.2 29.7-32.9 26.9-35.7
Stage 2, n (%) 3 11 8 2 24 (13.1) 28.3 ± 3.2 27.0-29.6 22.0-34.6
Stage 3, n (%) 3 12 33 20 68 (37.2) 25.6 ± 3.2 24.9-26.4 19.3-32.0
Stage 4, n (%) 0 9 25 47 81 (44.3) 22.7 ± 4.3 21.7-23.6 14.0-31.4
aIn nine cases, we retained the lowest temperature of the thermometer as the actual temperature
b95 % prediction intervals were calculated assuming normality as mean ± 2SD
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(Stage 4) had an excellent outcome, 61 out of the 71
Stage 4 patient for whom outcome information was
available (85 %) having a CPC at 1. Whether the initial
cardiac arrest was correctly diagnosed in these
patients is also a matter of debate, as minimal vital
signs can be easily missed in Stage 3 deeply
hypothermic patients, especially if the search is not
carried out scrupulously [5, 11].
Fig. 2 ROC curves and optimal core body temperature thresholds in °C for stage discrimination. The temperature which best distinguishes
between stages was taken as the temperature value which maximises the sum of sensitivity plus specificity. Using estimated optimal thresholds
increased (sensitivity + specificity) from 128 to 155 for the stage 1/2 threshold, from 136 to 141 for the stage 2/3 threshold and from 129 to 133
for the Stage 3/4 threshold. Actual cut = accepted threshold for current clinical Swiss staging system [4]; Optimal cut = optimal threshold i.e. the
temperature at which the sum sensitivity + specificity is maximal; AUC = area under the curve
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Temperature ranges and estimates of optimal
temperature thresholds
We showed clearly that there were important overlaps
between the four stage groups with respect to core
temperature which indicates that accurate diagnosis of
hypothermic stage cannot be based solely on temperature.
This suggests that it might be preferable to associate the
various stages with overlapping temperature ranges, based -
for example - on the last column of Table 3. We also note
that the average temperature observed in the Stage 1 group
was below the theoretical lower boundary for this stage,
whilst the average temperature observed in the Stage 2
group was close to theoretical lower boundary; this suggests
that a redefinition of the temperature ranges associated
with the different clinical stages may be necessary.
Modifying thresholds of temperatures distinguishing the
different stages
As mentioned above, it would be more correct to associ-
ate overlapping ranges of temperature, respectively a
minimal temperature associated to the different clinical
stage groups, rather than to consider thresholds of
temperature to distinguish the different stages, set at re-
spectively 32 °C, 28 °C and 24 °C, as done so far. If one
would like to keep these thresholds, one may need to
study how to modify the definition of the clinical stages
to improve the percentage of correct classification, in
particular to minimize the proportion of patients for
whom the temperature is overestimated. An alternative
possibility would be to study how to modify the thresh-
olds of temperatures to improve the situation. Obvi-
ously, decreasing the thresholds would minimize the
proportion of patients for whom the temperature is
overestimated, at the cost of increasing drastically the
proportion of patients for whom the temperature is
underestimated. Some discussion should take place here
to establish what would be the most desirable comprom-
ise between underestimation and overestimation of the
temperature. It was to explore such possible compromises
that we performed a ROC analysis (although technically we
had to consider in this analysis the temperature as the pre-
dictor and the clinical stage as the outcome since a pre-
dictor in a classical ROC analysis has to be a quantitative
variable). Our estimates of the optimal thresholds for dis-
criminating between the stage 1 and stage 2 groups and the
stage 2 and stage 3 groups were lower than the currently
accepted ones (30.0 °C vs. 32 °C and 26.6 °C vs. 28 °C
respectively). The currently accepted stage 1/2 threshold
does not even fall within the 95 % bootstrap CI for the esti-
mated optimal threshold. In contrast, our estimated opti-
mal stage 2/3 threshold was not significantly lower than the
accepted threshold, which falls within the 95 % bootstrap
CI for our estimated threshold. Our estimated optimal
stage 3/4 threshold was remarkably close to the accepted
threshold (24.1 °C vs. 24 °C respectively). Overall core body
temperature discriminated best between the Stage 1 and
Stage 2 groups (see also the AUC values).
Our estimated thresholds are not too far from the ac-
cepted thresholds, although one could decrease the stage1/
2 threshold from 32 °C to 30 °C, and the stage 2/3 thresh-
old from 28 °C to 27 °C. The clinical consequence of such
changes would be a slight reduction of the percentage of
patients for whom the temperature is overestimated (in our
data, from 19.7 % to 15.8 %), while keeping the percentage
of patients for whom the temperature is underestimated at
around 33 %, yielding hence a greater appreciation of the
risk of cardiac arrest, which has implications for patient
management and the decision about orientating the patient
to the most appropriate treatment facility.
Others
While including the first patients we noted that presence
of shivering was very seldom reported. In only 11 cases
was this data reported: 8 where shivering was present
and 3 where it was absent. Five patients of the eight with
shivering were colder than the temperature indicated by
clinical staging, and most were young and active. The
lowest temperature recorded in presence of recorded
shivering was 21 °C (core) in a 44 year-old patient [12].
The ‘reassuring’ nature of the presence of shivering
should perhaps be reconsidered, with rescuers consider-
ing the possibility of deep hypothermia even in the pres-
ence of shivering, and being careful with resuscitation.
Limitations
Our study suffers from some limitations. An important
one is the risk of publication bias. The published cases
may not be representative of clinical practice; this
suggestion is supported by the high number of
favourable outcomes and the relative paucity of moder-
ately hypothermic cases. These low numbers should be
taken into account when considering our optimal
thresholds estimations. We were nevertheless obliged to
rely mainly on case reports, as we required accurate de-
scriptions of clinical status. This method however pro-
vides better evidence for the link between Swiss clinical
stages and core temperature. Another limitation comes
from the reliability of the temperature measurement,
which is known to be influenced by the type of probe
used or - especially in the pre-hospital setting – by en-
vironmental factors [13].
The choice of the GCS and AVPU scores as a method
of clinical classification is another potential limitation.
The categories ‘A’ and ‘U’ have, however, been shown to
correspond reliably to GCS scores of 15 and 3 respect-
ively [14]. There is also some overlap between categor-
ies, the median GCS scores associated with ‘P’ and ’U’
responses are 13 and 8, respectively [14, 15]. Using the
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GCS and AVPU scores produce more reproducible
results than using the terms ‘clearly conscious’, ‘impaired
consciousness’ and ‘unconscious’ as in the original
staging guidelines, and could serve as a common refer-
ence for further studies.
We were unable to use the criteria of presence or
absence of shivering presence in our analyses, because of
the paucity of cases where this information was available.
The wide range of temperatures observed in both shiver-
ing and non-shivering patients does, however, make us
dubious about the discriminative power of shivering, at
least as a sole criterion. Further prospective studies or
better reporting of the presence or absence of shivering in
hypothermia cases reports would enable us to gain a
better understanding of the value of this criterion.
Finally, as with any retrospective chart review, the qual-
ity of the data (including the accuracy of temperature
measurement) and the relative sample size could also
limit our conclusions.
Conclusion
Measured core body temperature corresponded to the
clinical stage in the Swiss staging model of hypothermia
in only about 50 % of the cases. Misclassification that
lead to underestimation of actual core body temperature
are usually benign and lead only to over-utilization of
the resources, whereas overestimation of core body
temperature has potentially serious consequences for the
patient. The estimated optimal temperature thresholds
for the various stages are not too far from the currently
accepted thresholds, although it may be appropriate to
decrease the thresholds for stage 1/2 and stage 2/3, as
we found. This may allow a slight reduction in the number
of cases where core body temperature is overestimated,
avoiding some potentially negative consequences for the
management of hypothermic patients. However, it would
probably be more sensible to associate overlapping ranges
of temperatures to the four groups defined by the Swiss
staging procedure, whereas the most cautious and safe
approach would be to use the lower published temperature
for each clinical stage. Identifying clinical indicators allow-
ing a better prediction of the core body temperature would
also be useful given the limitations on field temperature
measurement. A better reporting of clinical signs by
retrieval teams, or at best dedicated prospective studies
would be therefore helpful to better predict core body
temperature from the clinical state of hypothermic patients.
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